Copyright
©The Author(s) 2024.
World J Clin Oncol. Jul 24, 2024; 15(7): 840-847
Published online Jul 24, 2024. doi: 10.5306/wjco.v15.i7.840
Published online Jul 24, 2024. doi: 10.5306/wjco.v15.i7.840
Figure 1 Comparative survival analysis of hyperthermic intraperitoneal chemotherapy vs cytology-positive and cytology-negative groups.
HIPEC: Hyperthermic intraperitoneal chemotherapy.
Figure 2
Recurrence patterns post-gastrectomy with and without hyperthermic intraperitoneal chemotherapy adjunct.
- Citation: Methasate A, Parakonthun T, Intralawan T, Nampoolsuksan C, Swangsri J. Impact of hyperthermic intraperitoneal chemotherapy on gastric cancer survival: Peritoneal metastasis and cytology perspectives. World J Clin Oncol 2024; 15(7): 840-847
- URL: https://www.wjgnet.com/2218-4333/full/v15/i7/840.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i7.840